The Process: Switching From Wegovy to Zepbound Currently, there are no specific guidelines for switching from Wegovy to Zepbound, but lets look at what a healthcare professional might consider
doi:10.1186/s12958-018-0437-8
GLP-1 Receptor Activation This is the same pathway used by Semaglutide (Ozempic, Wegovy): Suppresses appetite via hypothalamic signaling Delays gastric emptying , prolonging fullness Improves insulin secretion and glucose control Lowers postprandial glucose and insulin resistance GIP Receptor Activation Shared with Tirzepatide, GIP provides several synergistic effects: Enhances insulin release in response to meals May reduce GI side effects (like nausea) seen with GLP-1s alone Potentially improves lipid metabolism and adipose tissue response Glucagon Receptor Activation This is where Retatrutide takes a leap beyond dual agonists: Increases energy expenditure and fat oxidation Mobilizes stored fat through hepatic lipolysis May preserve or enhance lean mass during weight loss Supports brown fat activation and thermogenesis The addition of glucagon receptor activation to GLP-1 and GIP may enhance fat oxidation and energy burn beyond whats seen with dual agonists. Coskun et al., Cell Metabolism Together, these pathways work synergistically: GLP-1 blunts hunger , GIP improves insulin dynamics , and glucagon turns up fat-burning efficiency
How they work Phentermine medications like Adipex-P and Qsymia work by stimulating certain neurotransmitters in the brain to help suppress appetite , reduce food cravings, and help you feel full more quickly
100 mg Arginine alpha-ketoglutarate (AAKG)
